Printer Friendly

Lilly Diabetes Partners on Diabetes with U.S. Auto Racing Organisation NASCAR.

M2 PHARMA-March 6, 2017-Lilly Diabetes Partners on Diabetes with U.S. Auto Racing Organisation NASCAR


- US-based pharmaceutical company Eli Lilly and Co (NYSE: LLY) Lilly Diabetes business is expanding its involvement in US-based stock car racing organisation NASCAR with a multi-year official partnership with the sanctioning body, Lilly said.

The new collaboration designates Lilly Diabetes as the "Official Diabetes Health Partner of NASCAR."

This partnership with Lilly Diabetes builds upon its primary sponsorship of the No. 16 Ford Mustang driven by Roush Fenway Racing's Ryan Reed, who last weekend won his second career NASCAR XFINITY Series race at Daytona International Speedway.

Additionally, as a part of this new partnership, Lilly Diabetes will work with NASCAR on multiple health and wellness initiatives, including launching an editorial series on

As the Official Diabetes Health Partner of NASCAR, Lilly Diabetes part of Eli Lilly and Company (NYSE: LLY) will expand its presence in the sport by introducing initiatives that educate fans about the disease.

Lilly encourages fans to stay determined and take action to better manage their diabetes by talking to their doctor and making lifestyle changes like exercising and eating healthy.

Approximately 30m Americans have diabetes, and if current trends continue, one in three US adults will develop diabetes by 20501, making this partnership particularly important.

Lilly Diabetes has played a significant role in the NASCAR community since 2013, when it first sponsored Roush Fenway Racing driver Ryan Reed and his No. 16 Lilly Diabetes Ford Mustang in the NASCAR XFINITY Series.

Ryan has type 1 diabetes and, through his work with Lilly, travels the NASCAR circuit raising awareness about the disease and encouraging fans to take action to better manage their diabetes.

Everyone's journey with diabetes is different, requiring ongoing, rigorous management that can often be a burden for people with the disease.

Through the sponsorship of Reed, and now the partnership with NASCAR, Lilly Diabetes wants to help fans see how small changes can add up to big wins in diabetes management, both on and off the track.

The National Association for Stock Car Auto Racing, Inc. (NASCAR) is the sanctioning body for the No. 1 form of motorsports in the United States.

NASCAR consists of three national series (Monster Energy NASCAR Cup Series, NASCAR XFINITY Series, and NASCAR Camping World Truck Series), four regional series, one local grassroots series and three international series.

The International Motor Sports Association (IMSA) governs the IMSA WeatherTech SportsCar Championship, the premier US sports car series.

Based in Daytona Beach, Florida, with offices in eight cities across North America, NASCAR sanctions more than 1,200 races in more than 30 US states, Canada, Mexico and Europe.

Lilly has been in diabetes care since 1923, when we introduced the world's first commercial insulin.

((Comments on this story may be sent to

COPYRIGHT 2017 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Mar 6, 2017
Previous Article:US FDA approves Noctiva Nasal Spray as Treatment for Frequent Urination at Night.
Next Article:Lilly Touts Taltz Study Results in Moderate-to-Severe Plaque Psoriasis.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |